MedImmune has expanded access for eligible premature infants to receive medication administered to high-risk infants for the prevention of serious lower respiratory tract infections caused by respiratory syncytial virus (RSV). The MedImmune Assistance Program is designed to provide the medicine for free to qualifying patients who lack health insurance and whose family household income is within a certain range of the federal poverty level (FPL) guidelines. The company recently increased the eligibility for the program to 400 percent of the FPL (e.g. a household of four with an income up to $88,200, and without health care coverage or medical insurance could receive medication at no cost). This is an expansion of the program’s previous eligibility ceiling. The MedImmune Assistance Program is administered as part of the Synagis Reimbursement Hotline and can be reached by calling 1-877-778-9010. More information about additional help available for RSV prevention and treatment can be found by visiting https://www.panfoundation.org/. For more information about RSV, go to http://www.synagis.com/what-is-rsv.aspx.